Lung cancer study reveals hidden nutrition crisis in targeted therapy
NCT ID NCT07559526
First seen May 08, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This study looked at the nutrition and body composition of 25 people with non-small-cell lung cancer who were taking the drug osimertinib. Researchers measured weight, muscle mass, and diet, and checked for muscle loss and weakness. The goal was to understand how nutrition relates to treatment side effects and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Hospital Complex of Vigo
Vigo, Pontevedra, 36312, Spain
Conditions
Explore the condition pages connected to this study.